CNTB

Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company based in Taicang, China, focused on developing innovative immune modulators for severe autoimmune diseases and inflammatory conditions. The firm boasts a promising pipeline of therapeutic candidates aimed at addressing significant unmet medical needs, underscoring its potential to deliver groundbreaking treatments that enhance patient outcomes. By leveraging advanced scientific research, Connect Biopharma is strategically positioned to play a pivotal role in the global biopharmaceutical market, pursuing sustainable growth and a lasting impact on healthcare.